China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effect of Recombinant Human Brain Natriuretic Peptide on Myocardial Matrix Degradation, Endothelial Glycocalyx Injury, and Endogenous Protective Mechanisms in Patients with Acute Heart Failure: A Study Based on TIMP-3, Syndecan-4, and PIII-NP'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136741
Registration Time: 2026/11/15
Type: Observational study
Primary Sponsor: Zhujiang Hospital of Southern Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353276
Published by HT Digital Content Services with permission from Health Daily Dig...